These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22910418)

  • 1. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization.
    Hasegawa-Moriyama M; Ohnou T; Godai K; Kurimoto T; Nakama M; Kanmura Y
    Biochem Biophys Res Commun; 2012 Sep; 426(1):76-82. PubMed ID: 22910418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.
    Takahashi Y; Hasegawa-Moriyama M; Sakurai T; Inada E
    Anesth Analg; 2011 Aug; 113(2):398-404. PubMed ID: 21490083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages.
    Hasegawa-Moriyama M; Kurimoto T; Nakama M; Godai K; Kojima M; Kuwaki T; Kanmura Y
    Pain; 2013 Aug; 154(8):1402-12. PubMed ID: 23707273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral administration of morphine attenuates postincisional pain by regulating macrophage polarization through COX-2-dependent pathway.
    Godai K; Hasegawa-Moriyama M; Kurimoto T; Saito T; Yamada T; Sato T; Kojima M; Kanmura Y
    Mol Pain; 2014 Jun; 10():36. PubMed ID: 24928142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
    Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y
    Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model.
    Hong GS; Schwandt T; Stein K; Schneiker B; Kummer MP; Heneka MT; Kitamura K; Kalff JC; Wehner S
    Br J Surg; 2015 Nov; 102(12):1506-16. PubMed ID: 26313905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ.
    Feng X; Qin H; Shi Q; Zhang Y; Zhou F; Wu H; Ding S; Niu Z; Lu Y; Shen P
    Biochem Pharmacol; 2014 Jun; 89(4):503-14. PubMed ID: 24704474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
    Hu Y; Zhang H; Lu Y; Bai H; Xu Y; Zhu X; Zhou R; Ben J; Xu Y; Chen Q
    Basic Res Cardiol; 2011 Nov; 106(6):1311-28. PubMed ID: 21769674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
    Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
    Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
    Zhong X; Liu H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice.
    Kawanishi N; Yano H; Yokogawa Y; Suzuki K
    Exerc Immunol Rev; 2010; 16():105-18. PubMed ID: 20839495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
    El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.